FDA Drug Recalls

Recalls / Class III

Class IIID-0036-2016

Product

Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box, Distributed by Target Corp, Minneapolis, MN 55403; NDC 11673-527-31, UPC 3 5166052731 5

Affected lot / code info
Batch Numbers: 2617892, 2617893, Exp 5/31/2016; 2625092, 2625093, Exp 6/30/2016; 2658137, 2658138, Exp 11/30/2016

Why it was recalled

Superpotent Drug: Out Of Specification (OOS) result for Assay.

Recalling firm

Firm
Ohm Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1385 Livingston Ave, N/A, North Brunswick, New Jersey 08902-1829

Distribution

Quantity
34,488 boxes
Distribution pattern
Nationwide.

Timeline

Recall initiated
2015-07-28
FDA classified
2015-10-15
Posted by FDA
2015-10-21
Terminated
2016-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0036-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.